DK1227095T3 - En fremgangsmåde til oprensningen af (S)-4-((3-(dimethylamino)ethyl)-1H-indol-5-yl)methyl-2-oxazolidinon - Google Patents

En fremgangsmåde til oprensningen af (S)-4-((3-(dimethylamino)ethyl)-1H-indol-5-yl)methyl-2-oxazolidinon

Info

Publication number: DK1227095T3
Authority: DK; Denmark
Prior art keywords: oxazolidinone; indol; dimethylamino; purification; ethyl
Prior art date: 1995-08-07

Application number

DK02008427T

Other languages

English (en)

Inventor

Rajnikant Patel

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-08-07

Filing date

1996-08-02

Publication date

2006-07-31

1996-08-02 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2006-07-31 Application granted granted Critical

2006-07-31 Publication of DK1227095T3 publication Critical patent/DK1227095T3/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/20—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Plural Heterocyclic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Indole Compounds (AREA)

DK02008427T 1995-08-07 1996-08-02 En fremgangsmåde til oprensningen af (S)-4-((3-(dimethylamino)ethyl)-1H-indol-5-yl)methyl-2-oxazolidinon DK1227095T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9516145.1A GB9516145D0 (en)	1995-08-07	1995-08-07	Improved chemical synthesis
PCT/GB1996/001885 WO1997006162A1 (en)	1995-08-07	1996-08-02	One pot synthesis of 2-oxazolidinone derivatives

Publications (1)

Publication Number	Publication Date
DK1227095T3 true DK1227095T3 (da)	2006-07-31

Family

ID=10778867

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
DK02008427T DK1227095T3 (da)	1995-08-07	1996-08-02	En fremgangsmåde til oprensningen af (S)-4-((3-(dimethylamino)ethyl)-1H-indol-5-yl)methyl-2-oxazolidinon
DK96926465T DK0843672T3 (da)	1995-08-07	1996-08-02	Enkeltreaktorsyntese af 2-oxazolidinonderivater

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
DK96926465T DK0843672T3 (da)	1995-08-07	1996-08-02	Enkeltreaktorsyntese af 2-oxazolidinonderivater

Country Status (34)

Country	Link
US (2)	US6084103A (da)
EP (2)	EP1227095B1 (da)
JP (6)	JP3729503B2 (da)
KR (1)	KR100670704B1 (da)
CN (3)	CN1092657C (da)
AR (2)	AR006515A1 (da)
AT (2)	ATE325121T1 (da)
AU (1)	AU718413B2 (da)
BR (1)	BR9609830A (da)
CA (2)	CA2572508C (da)
CZ (2)	CZ301603B6 (da)
DE (2)	DE69636107T2 (da)
DK (2)	DK1227095T3 (da)
ES (2)	ES2261545T3 (da)
GB (1)	GB9516145D0 (da)
HK (2)	HK1047094B (da)
HU (1)	HU229966B1 (da)
IL (4)	IL123171A (da)
IN (2)	IN185148B (da)
MX (1)	MX9801044A (da)
MY (1)	MY117571A (da)
NO (2)	NO311690B1 (da)
NZ (1)	NZ315040A (da)
PL (1)	PL188805B1 (da)
PT (2)	PT1227095E (da)
RO (2)	RO119618B1 (da)
RU (1)	RU2167875C2 (da)
SI (2)	SI1227095T1 (da)
SK (1)	SK285052B6 (da)
TR (1)	TR199800182T1 (da)
TW (1)	TW358811B (da)
UA (1)	UA53625C2 (da)
WO (1)	WO1997006162A1 (da)
ZA (1)	ZA966711B (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU5851400A (en) *	1999-07-09	2001-01-30	Chugai Seiyaku Kabushiki Kaisha	Process for the preparation of aniline derivatives
ES2204302B2 (es)	2002-08-07	2005-03-01	Laboratorios Vita, S.A.	Procedimiento para la obtencion de un compuesto farmaceuticamente activo.
US20070173536A1 (en) *	2004-02-06	2007-07-26	Ciba Specialty Chemicals Holding Inc.	Crystalline forms of zolmitriptan
WO2006055964A2 (en) *	2004-11-19	2006-05-26	Teva Pharmaceutical Industries Ltd.	Zolmitriptan crystal forms
EP1942193A4 (en)	2005-08-25	2010-10-27	Ube Industries	METHOD FOR THE PRODUCTION OF OPTICALLY ACTIVE (S OR R) -AMINOIC ACID OR AN OPTICALLY ACTIVE (S OR R) -α-AMINO-ACID ESTER
WO2007083320A2 (en) *	2006-01-19	2007-07-26	Matrix Laboratories Ltd	Conversion of aromatic diazonium salt to aryl hydrazine
WO2008007390A2 (en) *	2006-07-10	2008-01-17	Natco Pharma Limited	An improved process for purification of zolmitriptan
WO2008018090A2 (en) *	2006-08-09	2008-02-14	Matrix Laboratories Ltd	An improved process for the preparation of zolmitriptan
CZ2007158A3 (cs) *	2007-02-26	2008-10-22	Zentiva, A. S.	Zpusob prípravy zolmitriptanu
CZ301538B6 (cs) *	2007-02-26	2010-04-07	Zentiva, A. S.	Zpusob prípravy zolmitriptanu
WO2009044211A1 (en)	2007-10-03	2009-04-09	Generics [Uk] Limited	Process for the preparation of zolmitriptan, salts and solvates thereof
CN101230047B (zh) *	2008-02-04	2010-08-04	江苏中威药业有限公司	一种4-取代手性噁唑烷酮类化合物的制备方法
EP2387993B1 (en) *	2010-05-21	2012-11-07	Sanovel Ilaç Sanayi Ve Ticaret Anonim Sirketi	Orally disintegrating tablets of zolmitriptan and process for preparing the same
CN101948443B (zh) *	2010-08-17	2012-08-22	河南师范大学	一种简单、高效合成4-取代噁唑烷酮衍生物的方法
WO2012135615A2 (en)	2011-03-30	2012-10-04	Brown University	Enopeptins, uses thereof, and methods of synthesis thereto
EP2751098B1 (en)	2011-09-02	2017-11-29	Emcure Pharmaceuticals Limited	An improved process for preparation of zolmitriptan
CN102964270B (zh) *	2012-11-21	2015-01-07	合肥星宇化学有限责任公司	一种亚硫酸钠还原重氮盐合成肼的方法
CN103275075B (zh) *	2013-06-24	2015-01-07	成都天台山制药有限公司	佐米曲普坦及其制备方法
WO2016037072A2 (en) *	2014-09-04	2016-03-10	Brown University	Enopeptin analogas and methods of use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8724912D0 (en) *	1987-10-23	1987-11-25	Wellcome Found	Indole derivatives
WO1991018897A1 (en) *	1990-06-07	1991-12-12	The Wellcome Foundation Limited	Therapeutic heterocyclic compounds
GB9401436D0 (en) *	1994-01-26	1994-03-23	Wellcome Found	Therapeutic heterocyclic compounds
GB9423682D0 (en) *	1994-11-23	1995-01-11	Merck Sharp & Dohme	Therapeutic agents
US6025374A (en) *	1994-12-06	2000-02-15	Merck Sharp & Dohme, Ltd.	Azetidine, pyrrolidine and piperidine derivatives as 5HT1 receptor agonists

1995
- 1995-08-07 GB GBGB9516145.1A patent/GB9516145D0/en active Pending
1996
- 1996-02-08 UA UA98031096A patent/UA53625C2/uk unknown
- 1996-08-02 PT PT02008427T patent/PT1227095E/pt unknown
- 1996-08-02 CN CN96197237A patent/CN1092657C/zh not_active Expired - Lifetime
- 1996-08-02 NZ NZ315040A patent/NZ315040A/xx not_active IP Right Cessation
- 1996-08-02 AU AU66634/96A patent/AU718413B2/en not_active Expired
- 1996-08-02 DK DK02008427T patent/DK1227095T3/da active
- 1996-08-02 PT PT96926465T patent/PT843672E/pt unknown
- 1996-08-02 EP EP02008427A patent/EP1227095B1/en not_active Expired - Lifetime
- 1996-08-02 ES ES02008427T patent/ES2261545T3/es not_active Expired - Lifetime
- 1996-08-02 CN CNB01112010XA patent/CN1142904C/zh not_active Expired - Lifetime
- 1996-08-02 SI SI9630738T patent/SI1227095T1/sl unknown
- 1996-08-02 BR BR9609830A patent/BR9609830A/pt not_active Application Discontinuation
- 1996-08-02 RU RU98104085/04A patent/RU2167875C2/ru active
- 1996-08-02 JP JP50822697A patent/JP3729503B2/ja not_active Expired - Lifetime
- 1996-08-02 EP EP96926465A patent/EP0843672B1/en not_active Expired - Lifetime
- 1996-08-02 MX MX9801044A patent/MX9801044A/es unknown
- 1996-08-02 CA CA2572508A patent/CA2572508C/en not_active Expired - Lifetime
- 1996-08-02 IL IL12317196A patent/IL123171A/xx not_active IP Right Cessation
- 1996-08-02 CZ CZ20031498A patent/CZ301603B6/cs not_active IP Right Cessation
- 1996-08-02 RO RO98-00214A patent/RO119618B1/ro unknown
- 1996-08-02 IL IL148030A patent/IL148030A/en not_active IP Right Cessation
- 1996-08-02 SK SK154-98A patent/SK285052B6/sk not_active IP Right Cessation
- 1996-08-02 US US09/011,045 patent/US6084103A/en not_active Expired - Lifetime
- 1996-08-02 CN CNB011330929A patent/CN1244579C/zh not_active Expired - Lifetime
- 1996-08-02 CA CA002227039A patent/CA2227039C/en not_active Expired - Lifetime
- 1996-08-02 RO ROA200400914A patent/RO121816B1/ro unknown
- 1996-08-02 WO PCT/GB1996/001885 patent/WO1997006162A1/en not_active Application Discontinuation
- 1996-08-02 AT AT02008427T patent/ATE325121T1/de active
- 1996-08-02 HU HU9900188A patent/HU229966B1/hu unknown
- 1996-08-02 DE DE69636107T patent/DE69636107T2/de not_active Expired - Lifetime
- 1996-08-02 SI SI9630560T patent/SI0843672T1/xx unknown
- 1996-08-02 CZ CZ1998352A patent/CZ293050B6/cs not_active IP Right Cessation
- 1996-08-02 KR KR1019980700833A patent/KR100670704B1/ko not_active IP Right Cessation
- 1996-08-02 DK DK96926465T patent/DK0843672T3/da active
- 1996-08-02 DE DE69624825T patent/DE69624825T2/de not_active Expired - Lifetime
- 1996-08-02 AT AT96926465T patent/ATE227723T1/de active
- 1996-08-02 IL IL156733A patent/IL156733A/en not_active IP Right Cessation
- 1996-08-02 ES ES96926465T patent/ES2185790T3/es not_active Expired - Lifetime
- 1996-08-02 TR TR1998/00182T patent/TR199800182T1/xx unknown
- 1996-08-02 PL PL96324881A patent/PL188805B1/pl unknown
- 1996-08-06 IN IN1742DE1996 patent/IN185148B/en unknown
- 1996-08-06 MY MYPI96003220A patent/MY117571A/en unknown
- 1996-08-07 AR ARP960103909A patent/AR006515A1/es active IP Right Grant
- 1996-08-07 ZA ZA9606711A patent/ZA966711B/xx unknown
- 1996-10-01 TW TW085111923A patent/TW358811B/zh not_active IP Right Cessation
1998
- 1998-02-06 NO NO19980522A patent/NO311690B1/no not_active IP Right Cessation
- 1998-08-19 HK HK02108548.8A patent/HK1047094B/zh not_active IP Right Cessation
- 1998-08-19 HK HK98110000A patent/HK1009129A1/xx not_active IP Right Cessation
2000
- 2000-02-02 US US09/496,409 patent/US6160123A/en not_active Expired - Lifetime
- 2000-04-25 IN IN454DE2000 patent/IN189756B/en unknown
- 2000-10-16 NO NO20005187A patent/NO311691B1/no not_active IP Right Cessation
2001
- 2001-07-27 JP JP2001228781A patent/JP2002037786A/ja not_active Withdrawn
- 2001-07-27 JP JP2001228782A patent/JP3739678B2/ja not_active Expired - Lifetime
2002
- 2002-02-06 IL IL14803002A patent/IL148030A0/xx unknown
- 2002-03-26 JP JP2002086955A patent/JP2002308858A/ja not_active Withdrawn
2003
- 2003-05-02 AR ARP030101543A patent/AR046236A2/es active IP Right Grant
2005
- 2005-11-18 JP JP2005334990A patent/JP4634286B2/ja not_active Expired - Lifetime
2006
- 2006-05-31 JP JP2006152810A patent/JP2006225406A/ja not_active Withdrawn

Also Published As

Publication number	Publication date
BR9609830A (pt)	1999-03-09
CN1403455A (zh)	2003-03-19
CN1092657C (zh)	2002-10-16
HK1047094B (zh)	2006-10-13
KR19990036165A (ko)	1999-05-25
PT1227095E (pt)	2006-08-31
NO980522D0 (no)	1998-02-06
EP1227095A3 (en)	2003-11-19
IL123171A0 (en)	1998-09-24
CZ35298A3 (cs)	1998-06-17
ATE325121T1 (de)	2006-06-15
DE69624825D1 (de)	2002-12-19
JP3729503B2 (ja)	2005-12-21
CZ293050B6 (cs)	2004-01-14
HUP9900188A2 (hu)	1999-05-28
TW358811B (en)	1999-05-21
JP2006225406A (ja)	2006-08-31
RO121816B1 (ro)	2008-05-30
ES2261545T3 (es)	2006-11-16
JP2002308858A (ja)	2002-10-23
JPH11513023A (ja)	1999-11-09
KR100670704B1 (ko)	2007-07-11
PL188805B1 (pl)	2005-04-29
MY117571A (en)	2004-07-31
SK285052B6 (sk)	2006-05-04
PT843672E (pt)	2003-03-31
SK15498A3 (en)	1998-06-03
CA2572508C (en)	2010-03-30
HUP9900188A3 (en)	1999-11-29
HU229966B1 (hu)	2015-03-30
EP0843672B1 (en)	2002-11-13
DK0843672T3 (da)	2003-02-17
JP3739678B2 (ja)	2006-01-25
EP1227095A2 (en)	2002-07-31
NO20005187L (no)	1998-02-06
CA2572508A1 (en)	1997-02-20
RU2167875C2 (ru)	2001-05-27
CA2227039C (en)	2007-12-04
IN185148B (da)	2000-11-25
IL156733A (en)	2007-07-04
CA2227039A1 (en)	1997-02-20
IL148030A (en)	2010-05-17
JP2002097178A (ja)	2002-04-02
US6160123A (en)	2000-12-12
CN1317480A (zh)	2001-10-17
IL123171A (en)	2003-10-31
WO1997006162A1 (en)	1997-02-20
ATE227723T1 (de)	2002-11-15
HK1009129A1 (en)	1999-05-28
IL148030A0 (en)	2002-09-12
DE69636107T2 (de)	2007-05-03
AU6663496A (en)	1997-03-05
CN1201460A (zh)	1998-12-09
ZA966711B (en)	1997-02-18
AR006515A1 (es)	1999-09-08
DE69624825T2 (de)	2003-09-04
US6084103A (en)	2000-07-04
NO311691B1 (no)	2002-01-07
NO980522L (no)	1998-02-06
NO311690B1 (no)	2002-01-07
MX9801044A (es)	1998-05-31
GB9516145D0 (en)	1995-10-04
PL324881A1 (en)	1998-06-22
SI1227095T1 (sl)	2006-08-31
NO20005187D0 (no)	2000-10-16
CN1244579C (zh)	2006-03-08
IN189756B (da)	2003-04-19
CN1142904C (zh)	2004-03-24
AR046236A2 (es)	2005-11-30
JP4634286B2 (ja)	2011-02-16
ES2185790T3 (es)	2003-05-01
IL156733A0 (en)	2004-02-08
DE69636107D1 (de)	2006-06-08
NZ315040A (en)	2000-01-28
EP1227095B1 (en)	2006-05-03
SI0843672T1 (en)	2003-04-30
JP2002037786A (ja)	2002-02-06
EP0843672A1 (en)	1998-05-27
CZ301603B6 (cs)	2010-04-28
HK1047094A1 (en)	2003-02-07
JP2006077025A (ja)	2006-03-23
RO119618B1 (ro)	2005-01-28
AU718413B2 (en)	2000-04-13
TR199800182T1 (xx)	1998-05-21
UA53625C2 (uk)	2003-02-17

Publication	Publication Date	Title
DK1227095T3 (da)	2006-07-31	En fremgangsmåde til oprensningen af (S)-4-((3-(dimethylamino)ethyl)-1H-indol-5-yl)methyl-2-oxazolidinon
DK0770615T3 (da)	2003-07-14	Fremgangsmåde til fremstilling af dihalogenazolopyrimidiner
DK0845956T4 (da)	2008-06-16	Fremgangsmåde til fremstilling af en tandbörste
DK0778068T3 (da)	2001-10-15	Fremgangsmåde til afvanding af en gas
DK0754756T3 (da)	2006-03-13	Fremgangsmåde til fremstilling af L-lysin
DK1445259T3 (da)	2006-10-16	Anvendelse af krystalformer for 2-methyl-thieno-benzodiazepin
DE69635853D1 (de)	2006-04-27	Gerät zur akustischen Korrektur
DE69620107D1 (de)	2002-05-02	Kristallisationsverfahren
DK0747119T3 (da)	2000-06-19	Fremgangsmåde til fremstilling af sorberingsmidler
DK0937068T3 (da)	2002-05-21	Fremgangsmåde til krystallisation af losartan
NO974169D0 (no)	1997-09-09	Fremgangsmåte for tetra-azacykloalkan-fremstilling
DK0824517T3 (da)	2002-11-18	Fremgangsmåde til fremstilling af lercanidipinhydrochlorid
ATE181880T1 (de)	1999-07-15	Druckverfahren
DK0839138T3 (da)	2004-09-27	Fremgangsmåde til fremstilling af N-substituerede 3-hydroxypyrazoler
DK0830337T3 (da)	2000-06-13	Fremgangsmåde til hydrogenering af iminer
DK0877738T3 (da)	2003-09-08	Fremgangsmåde til fremstilling af phenylimidazolidinderivater
DK0780446T3 (da)	2001-10-15	Fremgangsmåde til fremstilling af pigmenter
DK0888168T3 (da)	2002-02-18	Fremgangsmåde til rensning af procesgasser
DK0805806T3 (da)	2000-05-01	Fremgangsmåde til fremstilling af 4,10-diacetoxy-2alpha-benzoyloxy-5beta,20-epoxy-1,7beta-dihydroxy-9-oxotax-11-en-13alpha-
DK0842930T3 (da)	2002-07-15	Fremgangsmåde til syntese af benzothiophener
DK0837762T3 (da)	2001-02-05	Fremgangsmåde til fremstilling af løvtræselementer
DK0815092T3 (da)	1999-12-06	Fremgangsmåde til fremstilling af 1,2-benzisothiazolin-3-oner
DK1023292T3 (da)	2003-11-10	Fremgangsmåde til syntese af chlorpurinintermediater
DK0721929T3 (da)	2000-03-27	Fremgangsmåde til fremstilling af hydroxyalkoxybenzophenoner
BR9502793A (pt)	1997-09-23	Suporte ortodôntico